[The so-called myoblastic myoma and its malignant disease course].
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D009062:Mouth Neoplasms / Q000175:diagnosis*; D009132:Muscles / Q000473:pathology; D009379:Neoplasms, Muscle Tissue / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D012208:Rhabdomyosarcoma / Q000473:pathology; D014062:Tongue Neoplasms / Q000175:diagnosis / Q000473:pathology
D000970:Antineoplastic Agents
Das sogenannte Myoblastenmyom und seine maligne Verlaufsform.